基于核糖蛋白的CRISPR/Cas9基因组联合编辑在阿斯伯吉洛斯luchuensis突变.
Takefumi Karashima1, Ken Oda2, Taiki Futagami3
1Sanwa Research Institute, Sanwa Shurui Co., Ltd., 2231-1 Yamamoto, Usa, Oita 879-0495, Japan.
Journal of bioscience and bioengineering
|August 7, 2025
概括
我们开发了一种CRISPR/Cas9基因组编辑方法,用于Aspergillus luchuensis mut. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈 这种基于核糖核蛋白的高效技术允许在模型和工业菌株中进行基因淘汰.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 基因工程是一种基因工程.
背景情况:
- 这是一种Aspergillus luchuensis突变的植物. 卡瓦奇是一种具有工业意义的真菌.
- 有效的基因组编辑工具对于A. luchuensis mut.的遗传操纵至关重要. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈
研究的目的:
- 建立基于核糖蛋白的聚类定期间隔的短时间palindromic重复 (CRISPR) /CRISPR相关蛋白9 (Cas9) 基因组联合编辑方法,用于A. luchuensis mut. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈
- 为了优化原生质的准备,以便有效地输送CRISPR/Cas9组件.
- 证明该方法在模型和工业菌株中用于基因淘汰和联合编辑的适用性.
主要方法:
- 使用Yatalase -Plus-.使用原生质制剂的优化.
- 在A. luchuensis mut.中引入单指导RNA-Cas9核糖蛋白复合体. 卡瓦奇原生质. 卡瓦奇原生质.
- ATP硫酶编码sC基因的基因淘汰.
- 基因组联合编辑针对sC与pyrG或prtR基因.
主要成果:
- 成功优化了对A. luchuensis mut.的原始质细胞制备. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈
- 在NBRC4308和No.308中有效地淘汰了sC基因. 8046种菌株. 这些菌株.
- 在NBRC 4308中成功进行基因组联合编辑以产生pyrG和prtR淘汰菌株.
- 在工业No.1中成功生成prtR淘汰菌株. 8046 菌株. 菌株. 在 8046 菌株.
结论:
- 基于核糖蛋白的CRISPR/Cas9基因组联合编辑方法对A. luchuensis mut.有效. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈
- 这种方法适用于模型和工业菌株,为基因操纵提供了一种多功能工具.
- 开发的方法对未来的研究和应用在A. luchuensis mut.中充满希望. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈
关键词:
这是一种Aspergillus luchuensis突变的植物. 哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈这就是CRISPR/Cas9的作用.基因组联合编辑核糖蛋白是一种核糖蛋白.雅塔酶-加上-更多相关视频
相关概念视频
01:28CRISPR/Cas9 Genome Editing
227
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
227
01:59CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
02:53CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K
02:31Homologous Recombination
52.0K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.0K